BATS BZX Real-Time Price
As of 10:00am ET
| -0.05 / -0.33%|
The 8 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 22.00, with a high estimate of 51.00 and a low estimate of 16.00. The median estimate represents a +46.18% increase from the last price of 15.05.
The current consensus among 9 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.